PR

Periganji Radhakrishna Ishwarya

Director Additional Director DIN 09777342
DIN 09777342 First appointment Nov 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Periganji Radhakrishna Ishwarya

Data last updated:

Periganji Radhakrishna Ishwarya was an Additional Director at Retra Life Sciences Private Limited (2022–2025). The company operates in Pharma.

DIN 09777342
Primary Designation Additional Director
Industry Pharma
First Appointment 10 Nov 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Retra Life Sciences Private Limited U24239KA2019PTC128286
Additional Director10 Nov 20222019₹4.29 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Retra Life Sciences Private Limited
Premium access

Shareholding and investment profile for Periganji Radhakrishna Ishwarya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Periganji Radhakrishna Ishwarya

Periganji Radhakrishna Ishwarya was first appointed on 10 Nov 2022 as Additional Director at Retra Life Sciences Private Limited.

Periganji Radhakrishna Ishwarya held 1 earlier board appointment: Retra Life Sciences Private Limited (Additional Director, 10 Nov 2022 to 10 Oct 2025).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available